ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1202

Two Family Kindreds With Blau’s Syndrome Associated With Unusual NOD2 Mutations

Qingping Yao, Rheumatic and Immunologic Dis, Cleveland Clinic, Cleveland, OH

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Blau syndrome, Genetic Biomarkers, genetic disorders and nod-like receptor (NLR), Rashes

  • Tweet
  • Email
  • Print
Session Information

Title: Miscellaneous Rheumatic and Inflammatory Diseases I: Autoinflammatory Syndromes

Session Type: Abstract Submissions (ACR)

Background/Purpose:

The aim of this study was to report families of Blau’s syndrome with unusual NOD2 gene variants.

Methods:

Two proband patients were seen, and their clinical phenotypes and genotypes were analyzed. Pedigree charts of both families were made.

Results:

Proband A, a white 57-year-old woman, noticed painless flexion contractures of her 3rd, 4th and 5th proximal interphalangeal joints (PIPs) of both hands at age 6. She developed inflammatory polyarthritis and intermittent facial erythematous plaques/patches since age 30. As a result of cough and dyspnea, chest radiograph and computerized tomography showed multiple lung nodules without hilar adenopathy noted, and subsequent mediastinal lymph node biopsy revealed noncaseating granuloma. These symptoms markedly improved with prednisone 40 mg daily with taper. She had dry eyes on cyclosporine drops without uveitis. There were right parotid gland enlargement consistent with peiomorphic adenoma and left scanty granuloma composed of lymphocytes and mixed with debris and rare collections of histocytes. There was low grade fever. Her erythrocyte sedimentation rate (ESR), antinuclear antibodies, and blood CD4, CD8, and NK cell counts were all normal.  Her blood vascular endothelial growth factor and TNFa levels were normal. A positive family history included flexion contractures of the 4th and 5thPIPs (Photographs and Pedigree chart). On examination, there was camptodactyly of the PIPs 3, 4 and 5 of both hands. Genetic testing revealed the presence of the NOD2 variant IVS8+158 in the patient, daughter and son.

Proband B, a white 50-year-old woman, developed inflammatory polyarthritis during the previous 5 months. She also had aching skin and subcutaneous nodules over her elbows, wrists and knees.  She complained of mild dry eyes and mouth without parotid gland enlargement or fever; ophthalmic examination showed no evidence of uveitis. A positive family history involved flexion contractures of the 5thPIPs in several members (Pedigree chart). On examination, there were minimally tender and mobile subcutaneous nodules of 0.5 to 1.5 cm over the joints (Photograph). Her ESR and serologic testing were normal. A skin nodule biopsy showed non-necrotizing granuloma. Genetic testing revealed the presence of the NOD2 mutation R703C. These nodules resolved after 2 months of treatment with sulfasalazine.

Conclusion:

Both families have autosomal dominant phenotypes of Blau’s syndrome.  Proband A has familial NOD2 IVS8+158, and proband B is linked to the NOD2 R703C. This study indicates that Blau’s syndrome is also associated with the NOD2 variants away from the commonly reported nucleotide binding region and may present as an adult-onset disease.


Disclosure:

Q. Yao,
None;

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/two-family-kindreds-with-blaus-syndrome-associated-with-unusual-nod2-mutations/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology